Dishman Carbogen Amics (NSE:DCAL) Current Accrued Expense: ₹ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:DCAL Dishman Carbogen Amics Ltd NSE:DCAL
67 GF Score
Price ₹170.52
GF Value ₹182.80
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dishman Carbogen Amics Current Accrued Expense?

Dishman Carbogen Amics NSE:DCAL +5.19% 67 Current Accrued Expense is ₹ Mil as of Jun. 2026. GuruFocus rates NSE:DCAL with a GF Score™ of 67/100 and a GF Value™ of ₹182.80 (Fairly Valued). The stock has 3 warning signs investors should review.

Dishman Carbogen Amics's Current Accrued Expense for the quarter that ended in Jun. 2026 was ₹ Mil.

Dishman Carbogen Amics Current Accrued Expense Related Terms

Dishman Carbogen Amics Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Dishman Carbogen Amics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dishman Carbogen Amics Current Accrued Expense Chart

Dishman Carbogen Amics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dishman Carbogen Amics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
NSE:DCAL
67GF Score
Dishman Carbogen Amics Ltd NSE:DCAL
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dishman Carbogen Amics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of ₹ Mil mean?
Dishman Carbogen Amics (NSE:DCAL) has a Current Accrued Expense of ₹ Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Dishman Carbogen Amics and its competitors.
Is Dishman Carbogen Amics' Current Accrued Expense too high?
Dishman Carbogen Amics' current Current Accrued Expense is ₹ Mil. Overall, Dishman Carbogen Amics has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dishman Carbogen Amics' Current Accrued Expense compare to VRTX and REGN?
Dishman Carbogen Amics' Current Accrued Expense of ₹ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Dishman Carbogen Amics and its competitors. Dishman Carbogen Amics's current Current Accrued Expense is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dishman Carbogen Amics stock overvalued right now?
Based on GuruFocus' analysis, Dishman Carbogen Amics (NSE:DCAL) is currently considered Fairly Valued. The stock's GF Value™ is ₹182.80, compared to a current price of ₹170.52 — trading 6.7% below its estimated fair value. The current Current Accrued Expense is ₹ Mil. Dishman Carbogen Amics' overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Dishman Carbogen Amics (NSE:DCAL), the current Current Accrued Expense is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dishman Carbogen Amics (NSE:DCAL) Overvalued in 2026?

Based on GuruFocus' analysis, Dishman Carbogen Amics stock appears to be undervalued. The current stock price of ₹170.52 is trading 6.7% below its estimated GF Value™ of ₹182.80. GuruFocus considers Dishman Carbogen Amics to be Fairly Valued.

Key valuation signals for NSE:DCAL:

  • Current Accrued Expense: ₹ Mil
  • GF Value™: ₹182.80 vs. price of ₹170.52 (6.7% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the NSE:DCAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dishman Carbogen Amics Business Description

Other Exchanges 540701:India
Address Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.
67GF Score

Get the complete analysis for NSE:DCAL

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹170.52
Price
₹182.80
GF Value